In the quiet architecture of the brain's hypothalamus, a single protein called Menin appears to hold back the tide of ageing — and when it recedes, as it naturally does over time, the body follows. Researchers at Xiamen University have traced a molecular chain from Menin's decline to inflammation, cognitive loss, and shortened life in animal models, identifying a specific guardian in a specific place. The discovery does not promise a cure, but it does something perhaps more valuable: it gives science a precise place to look, and a reason to believe that ageing is not one fate but many small fa
Brain protein Menin emerges as key anti-ageing factor, study finds
Related Coverage
President Trump will award the Congressional Space Medal of Honor to the Artemis II crew for completing a historic 10-da…
News-Medical · Aug 24 Decade-long Scottish study finds screen time's effects on child development far more complex than fearedA Scottish longitudinal study tracking 3,786 children from ages 5-15 found screen use showed limited and inconsistent as…
Education News Canada · Aug 24 UNB researchers help confirm first evidence of elemental sulfur on MarsUniversity of New Brunswick researchers contributed to the first confirmed discovery of elemental sulfur on Mars, sugges…
South China Morning Post · Aug 24 Chinese researchers develop compact X-ray camera for real-time medical imaging with lower radiationA Chinese research team has created a tabletop X-ray camera that captures dynamic medical imaging with lower radiation d…
Bias & Framing
Science reporting presents preliminary mouse study findings on Menin protein with balanced language, though lacks critical discussion of translational limitations and human applicability.
Optimistic scientific discovery framing with emphasis on potential breakthrough; presents findings as significant without substantial caveats about animal model limitations or clinical distance.
Geopolitical Impact
Scientific discovery about brain protein Menin has no direct geopolitical implications; research conducted by Chinese institution may influence future biotech competition in longevity science.
Potential long-term strategic advantage for China in aging-related biotechnology research; could influence future pharmaceutical and longevity industry competition between major powers.
Economic Lens
Discovery of Menin protein's anti-ageing role may drive biotech innovation in cognitive health treatments and create markets for D-serine supplements and therapeutic interventions targeting neuroinflammation.
Consumers may see increased availability and marketing of D-serine supplements and anti-ageing brain health products. Long-term, successful therapeutics could reduce healthcare costs associated with cognitive decline and age-related diseases, improving quality of life and reducing caregiver burden for aging populations.
Regulatory bodies may need to establish guidelines for D-serine supplement safety and efficacy claims. Governments may increase R&D funding for gerontology research. Healthcare systems could shift focus toward preventive therapies targeting neuroinflammation. Patent protections for Menin-based therapeutics will likely emerge.